Objective : To determine the change in opinion about the treatment options of Turkish doctors who fight COVID in 2nd and 3rd level hospitals.
Method: A questionnary compromised of 14 questions is asked to clinicians in may 20221 and may 2022. The results are collected with Data alchemer, and the results are analyzed with IBM SPSS.
Results: Prednisolone, IV use of 60 and 80 mg when added to standart therapies was observed by clinicians more effective in 2022 than in 2021. Also, use of high doses of prednisolone (250 mg and higher) was defined trustworty in both years. ASA is used in routine treatment in both years. But there was a small decrease of trust in its effectiveness in 2022 than in 2021. Low Molecular Weight Heparine(LMWH), (especially Enoxaparine) is also used in the treatment of COVID for both years and a quite higher level of trust in its effectiveness was observed in 2022 than in 2021. For vaccines, use of BİONTECH is preferred by doctors, for themselves and their relatives if it is present.
Conclusion: During the pandemic, clinicians all over the world used a lot of treatment options to gain control over COVID, at the end it is well understood that there was no specific treatment but vaccines, steroids, ASA, low molecular weight heparin were the best agents to be used against symptoms and complications of COVID.In Turkiye also,as we concluded after our study ,clinicians are in favour of same medical agents as their global colleagues.
Keywords: COVID, Treatment,options, clinician, opinion
Key words: COVID, Treatment, options Clinician, Opinion,
|
